Français
Contact us
Help
Search
Canada Site
A-Z Index
Consultations
Media Room
It's Your
Health
Home
About Health Canada
Consumer Product Safety
Diseases & Conditions
Drugs & Health Products
Adverse Reaction Information
Advisories, Warnings & Recalls
Biologics, Radio-
pharmaceuticals & Genetic Therapies
Compliance & Enforcement
Controlled Substances & Precursor Chemicals
Drug Products
International Activities
MedEffect
Medical Devices
Medical Use of Marihuana
Natural Health Products
Public Involvement & Consultations
Regulatory Requirements for Advertising
Special Access to Drugs & Health Products
Substances: Problematic Use
Veterinary Drugs
Legislation & Guidelines
Reports & Publications
Emergencies & Disasters
Environmental & Workplace Health
First Nations & Inuit Health
Food & Nutrition
Health Care System
Healthy Living
Science & Research
Government
Health Partners
Need
Larger
Text?
Home
>
Drugs & Health Products
>
MedEffect
>
Advisories, Warnings & Recalls
>
For the Public
>
2004
2004
December
Warning not to use Lot 4G03 Artificial Tears Extra
Date: 2004/12/29
Safety information regarding selective COX-2 inhibitor NSAIDs: Vioxx (rofecoxib), Celebrex (celecoxib), Bextra (valdecoxib), Mobicox (meloxicam) and generic forms of meloxicam
Date: 2004/12/22
Medication errors involving Reminyl and Amaryl Janssen-Ortho Inc. and Aventis Pharma Inc
Date: 2004/12/21
Updated safety information on increased cardiovascular risk with Celebrex* (celecoxib)
Date: 2004/12/20
Updated safety: Possible relationship of Aredia and/or Zometa with osteonecrosis of the jaw
- Novartis Pharma Canada Inc.
Date: 2004-12-15
Pfizer Canada Inc. Issues Warnings about Bextra - Cardiovascular Risks and Serious Skin Reactions
- Pfizer Canada Inc.
Date: 2004-12-10
Health Canada warns Canadians that certain lots of a sedative (Novo-Lorazem) may contain pills of a different drug
Date: 2004-12-03
Updated Safety Information addressing the risk of malignancies associated
with REMICADE (infliximab)
-Schering Canada Inc.
Date: 2004-12-02
November
Urgent Product Removal Oral-B CrossAction Power and PowerMAX Toothbrushes and refills.
- Gillette
Date: 2004-11-30
Health Canada warns consumers not to use Male Power Plus
Date: 2004-11-26
Updated Safety Information regarding Crestor
®
Date: 2004-11-24
Health Canada warns against using Blue Cap shampoo and spray
Date: 2004-11-20
Notification to CLARION 1.2 cochlear implant users.
- Advanced Bionics
Date: 2004-11-09
Notification to CLARION CII cochlear implant users.
- Advanced Bionics
Date: 2004-11-09
Notification to HiRes 90K cochlear implant users.
- Advanced Bionics
Date: 2004-11-09
Safety Information on the LTV Series Ventilators
- Pulmonetic Systems
Date: 2004-11-04
Health Canada advises consumers to consult with their physicians on the use of Carbolith 150 milligram products
Date: 2004-11-01
October
Urgent Product Removal Oral-B CrossAction Power and PowerMAX Toothbrushes and refills.
- Gillette
Date: 2004-10-29
New Warnings about Parkinson’s Drug PERMAX
®
and Reports of Heart Valve Problems
- Shire BioChem Inc.
Date: 2004-10-26
Association of EPREX (epoetin alfa) with thrombotic vascular events
-Janssen-Ortho Inc.
Date: 2004-10-18
September
Health Canada informs Canadians of Vioxx withdrawal by Merck & Co.
Date: 2004/09/30
Important safety information for patients taking LAMICTAL (lamotrigine)
- GlaxoSmithKline Inc.
Date: 2004-09-27
Health Canada Advises Consumers to Return Euro-K and Riva-K Potassium Chloride Products
Date: 2004-09-01
August
Mallinckrodt, a division of Nellcor/Tyco Healthcare Issues Recall of TracheoSoft XLT Extended Length Tracheostomy Tube
-Tyco Healthcare
Date: 2004-08-20
Health Canada advises of potential adverse effects of SSRIs and other anti-depressants on newborns
Date: 2004-08-09
July
Possible Association between RITUXAN (rituximab) and the recurrence of Hepatitis B
- Hoffmann-La Roche Limited
Date: 2004-07-30
Health Canada advises consumers not to use the products containing ARISTOLOCHIC ACID
Date: 2004-07-27
Health Canada Warns Canadians Not to Use "SESA Hair Supplement"
Date: 2004-07-27
Health Canada is advising Canadians that antidepressant TRAZODONE may interact with certain medications
Date: 2004-07-08
June
Health Canada Advises Consumers Not to Ingest Teas or Health Products Containing STAR ANISE Unless it Is Identified as Chinese Star Anise
Date: 2004-06-29
ARAVA (leflunomide) and lung inflammation causing difficulty breathing
Date: 2004-06-24
Health Canada Takes Additional Safety Measures to Ensure the Safe Use of CLOZAPINE
Date: 2004-06-24
Health Canada Is advising Canadians about a possible association between CRESTOR and rhabdomyolysis
- AztraZeneca Canada Inc.
Date: 2004-06-24
Health Canada advises health professionals and consumers about PENICILLIN allergy test recall
Date: 2004-06-18
Health Canada is advising health professionals and patients regarding the recall of specific batches of PROGLYCEM
®
Date: 2004-06-04
Health Canada advises Canadians of stronger warnings for SSRIs and other newer anti-depressants
Date: 2004-06-03
May
Health Canada warns public not to use Thermonex
Date: 2004-05-28
Health Canada warns public not to use Bell Magnum Bullet
Date: 2004-05-26
Important New Safety Information on ORTHOCLONE OKT*3
(muromonab-CD3)
- Janssen-Ortho Inc.
Date: 2004-05-17
Emerging Safety Information: Diarrhea and Ischemic Colitis in Patients Using ZELNORM (tegaserod hydrogen maleate)
- Novartis Pharmaceuticals Canada Inc.
Date: 2004-05-13
April
Important Safety Information concerning Liver Problems for Patients taking ACCOLATE
®
(zafirlukast)
- AstraZeneca Canada Inc.
Date: 2004-04-19
March
Updated Safety Information for ZYPREXA (olanzapine) in Elderly Dementia Patients, Announced in Canada
- Eli Lilly Canada Inc.
Date: 2004-03-18
February
Health Canada advises Canadians under the age of 18 to consult physicians if they are being treated with newer anti-depressants
Date: 2004-02-03
PUBLIC ADVISORY - Information for patients regarding a drug interaction between RITONAVIR (Norvir/Kaletra) and FLUTICASONE propionate (Flonase, Flovent, Advair)
- GlaxoSmithKline Inc.
Date: 2004-02-02
January
PUBLIC ADVISORY - Updated Safety Information Announced in Canada for Patients Taking TOPAMAX* (topiramate) Regarding Higher than Normal Blood Acid Levels
- Janssen-Ortho Inc.
Date: 2004-01-26
PUBLIC ADVISORY - Updated Safety Information about EPREX* (epoetin alfa) Provided to Canadian Healthcare Professionals
- Janssen-Ortho Inc.
Date: 2004-01-15
Serious liver injury with TEBRAZID (pyrazinamide) or PMS-pyrazinamide and rifampin for the treatment of latent tuberculosis
- ICN Canada Limited and Pharmascience Inc.
Date: 2004-01-06
Last Updated: 2005-04-08
Important Notices